Details of the Drug

General Information of Drug (ID: DMK8EZD)

• Drug Name: DeTIL-0255

Indication

Disease Entry	ICD 11	Status	REF
Ovarian cancer	2C73	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DJ3QK6

References

• [1] ClinicalTrials.gov (NCT05107739) A Phase 1 Safety and Tolerability Study of DeTIL-0255 in Adults With Advanced Malignancies. U.S.National Institutes of Health.